Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable tranexamic acid in open transvesical prostatectomy for benign prostatic hyperplasia
IRCT20211121053127N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in benign prostatic hyperplasia (BPH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Hemoglobin level. Started Dec 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20211121053127N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053127N1.